abrdn plc Acquires New Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

abrdn plc bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, Holdings Channel.com reports. The firm bought 161,675 shares of the exchange traded fund’s stock, valued at approximately $14,436,000.

Other large investors have also recently modified their holdings of the company. James J. Burns & Company LLC raised its stake in shares of SPDR S&P Biotech ETF by 5.0% during the 3rd quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after purchasing an additional 146 shares during the period. Moser Wealth Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 10.4% in the third quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock worth $149,000 after buying an additional 193 shares in the last quarter. Viewpoint Capital Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 25.0% in the third quarter. Viewpoint Capital Management LLC now owns 1,000 shares of the exchange traded fund’s stock valued at $73,000 after acquiring an additional 200 shares during the period. HB Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 4.9% during the fourth quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock valued at $382,000 after acquiring an additional 200 shares in the last quarter. Finally, Global Retirement Partners LLC increased its holdings in SPDR S&P Biotech ETF by 9.1% during the 4th quarter. Global Retirement Partners LLC now owns 2,474 shares of the exchange traded fund’s stock worth $220,000 after acquiring an additional 206 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $83.93 on Thursday. The company’s 50 day simple moving average is $93.10 and its two-hundred day simple moving average is $84.57. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock has a market capitalization of $6.52 billion, a PE ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.